Edwards Lifesciences’ (EW) SAPIEN TAVR Study Outcome Favorable
ZacksEdwards Lifesciences’ (EW) recent study provides insights into the actual performance of small Edwards valves and reaffirms the excellent outcomes for patients receiving SAPIEN TAVR.